![](https://s3-eu-west-1.amazonaws.com/cjp-rbi-estatesgazette/wp-content/uploads/sites/3/2023/06/Matthew-Snape-300x300-1.jpg)
Professor Matthew Snape
Vice-president, paediatric and maternal vaccine clinical development, Moderna
Snape is a member of the Oxford Vaccine Group specialising in paediatrics and vaccinology. Recently, his work has involved analysing how children are affected by Covid-19, as well as what role they may play in spreading the virus.